Sulthiame
- Generic Name
- Sulthiame
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H14N2O4S2
- CAS Number
- 61-56-3
- Unique Ingredient Identifier
- I00Q766CZ2
- Associated Conditions
- Benign rolandic epilepsy
- Associated Therapies
- -
Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
Recruiting
- Conditions
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 15
- Registration Number
- NCT05885646
- Locations
- 🇫🇷
Strasbourg University Hospital, Pediatric department, Strasbourg, France
🇫🇷Angers University Hospital, Pediatric department, Angers, France
🇫🇷Toulouse University Hospital, Pediatric Neurology Department, Toulouse, France
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 298
- Registration Number
- NCT05236842
- Locations
- 🇧🇪
Pneumocare SRL, Namur, Belgium
Pharmacokinetics and Tolerability of Sulthiame
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Target Recruit Count
- 4
- Registration Number
- NCT03400189
- Locations
- 🇨🇭
Division of Clinical Pharmacology, Lausanne, Vaud, Switzerland
Population Pharmacokinetics of Antiepileptic in Pediatrics
Recruiting
- Conditions
- Interventions
- Biological: Valproic acidBiological: carbamazepineBiological: phenobarbitalBiological: phenytoinBiological: levetiracetamBiological: lamotrigineBiological: topiramateBiological: oxcarbazepineBiological: stiripentolBiological: clobazamBiological: brivaracétamBiological: felbamateBiological: lacosamideBiological: rufinamideBiological: gabapentineBiological: pregabalineBiological: sultiameBiological: tiagabineBiological: vigabatrineBiological: mesuximideBiological: primidoneBiological: perampanelBiological: ethosuximideBiological: zonisamideBiological: cannabidiolOther: genetic polymorphisms
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT03196466
- Locations
- 🇫🇷
AP-HP Cochin, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath